Internal Server Error

Ataraxis - About the company

Ataraxis is a series A company based in New York (United States), founded in 2022. It operates as a Provider of AI-based diagnostic platform. Ataraxis has raised $40.4M in funding from investors like Obvious Ventures, AIX Ventures and Giant Ventures. The company has 85 active competitors, including 33 funded and 4 that have exited. Its top competitors include companies like PAIGE, Ibex and Onc.ai.
Key Metrics
Founded Year
2022
Location
New York, United States
Stage
Series A
Total Funding
$40.4M in 2 rounds
Latest Funding Round
Ranked
Similar Companies
Sign up to download Ataraxis' company profile

Ataraxis's funding and investors

Ataraxis has raised a total funding of $40.4M over 2 rounds. Its first funding round was on Nov 01, 2024. Its latest funding round was a Series A round on Mar 05, 2025 for $*****. 6 investors participated in its latest round. Ataraxis has 5 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Ataraxis:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Mar 05, 2025
6481044
Series A
5470384
3328354
5801934
4060585
Nov 01, 2024
6236169
Seed
7581348
9896719
5808077
lockAccess funding benchmarks and valuations. Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Ataraxis's Competitors and alternates

Top competitors of Ataraxis include PAIGE, Ibex and Onc.ai. Here is the list of Top 10 competitors of Ataraxis, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for PAIGE
PAIGE
2018, New York City (United States), Acquired
Developer of AI applications and foundation models for cancer diagnostics
$241M
71/100
2nd
Logo for Ibex
Ibex
2016, Tel Aviv (Israel), Series C
Provider of AI-powered diagnostic solutions for pathology
$114M
69/100
3rd
Logo for Onc.ai
Onc.ai
2020, San Carlos (United States), Series A
AI-based cancer treatment and diagnosis platform for healthcare providers
$31M
62/100
4th
Logo for Proscia
Proscia
2014, Philadelphia (United States), Series C
Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
$129M
59/100
5th
Logo for Valar Labs
Valar Labs
2021, Palo Alto (United States), Series A
Developer of AI diagnostics for predicting cancer treatment response likelihood
$26.1M
61/100
6th
Logo for PreciseDx
PreciseDx
2019, New York City (United States), Series B
Provider of an AI-based medical image analysis software for healthcare professionals
$32M
59/100
7th
Logo for Harbinger Health
Harbinger Health
2008, Cambridge (United States), Series B
AI-based cancer detection tool for providers
$290M
57/100
8th
Logo for CDx Diagnostics
CDx Diagnostics
1997, Suffern (United States), Acquired
Provider of AI-based platform to detect precancerous tissues
$16M
57/100
9th
Logo for Mindpeak
Mindpeak
2017, Hamburg (Germany), Series A
Provider of AI-based pathological analysis platform
$18.3M
56/100
10th
Logo for Primaa
Primaa
2018, Paris (France), Series B
Provider of AI-based software for detection of cancer
$15.7M
55/100
19th
Logo for Ataraxis
Ataraxis
2022, New York (United States), Series A
Provider of AI-based diagnostic platform
$40.4M
46/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Ataraxis's competitors? Click here to see the top ones

Ataraxis's Investments and acquisitions

Ataraxis has made no investments or acquisitions yet.

Reports related to Ataraxis

Here is the latest report on Ataraxis's sector:

News related to Ataraxis

Media has covered Ataraxis for a total of 3 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Ataraxis

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford